AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Serco Group PLC

Transaction in Own Shares Mar 21, 2024

5273_rns_2024-03-21_f23ebaee-cdf9-459a-914f-f012b6430fb6.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6803H

Serco Group PLC

21 March 2024

Serco Group plc  

Legal Entity Identifier: 549300PT2CIHYN5GWJ21

Transactions in own shares

Serco Group plc (the 'Company') announces the purchase of 49,611 ordinary shares of 2 pence each (the 'Ordinary Shares') through Barclays Capital Securities Limited on 20 March 2024.

The Company intends to hold all of the purchased Ordinary Shares in treasury.

Since the announcement of the share buyback programme on 29 February 2024 (the 'Programme'), the Company has purchased a total of 4,396,394 Ordinary Shares.

Following the transactions referred to in this announcement, the Company holds 4,396,394 Ordinary Shares in treasury and has 1,099,149,572 Ordinary Shares in issue (excluding treasury shares). The total number of Ordinary Shares with voting rights will be 1,099,149,572 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

The table below contains detailed information about the purchases referred to above.

Schedule of Purchases

Shares purchased: Serco Group plc (ISIN: GB0007973794)
Date of purchases: 20 March 2024
Investment firm: Barclays Capital Securities Limited

Aggregate information:

Venue Aggregated number of ordinary shares purchased Volume-weighted average price per share (£) Lowest price per share (£) Highest price per share (£)
Aquis Exchange 1,765 1.8400 1.8400 1.8400
CBOE BXE 18,607 1.8395 1.8370 1.8400
CBOE CXE 7,184 1.8388 1.8380 1.8400
London Stock Exchange 18,881 1.8393 1.8370 1.8400
Turquoise 3,174 1.8380 1.8380 1.8380

In accordance with Article 5(1)(b) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation) detailed information about the individual purchases can be seen below.

Individual Transactions:

Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
20/03/2024 08:18:22 177 183.8 CHIX 592110659738099000
20/03/2024 08:18:22 385 183.8 TRQX 606184410199623000
20/03/2024 08:18:22 83 183.8 TRQX 606184410199623000
20/03/2024 08:18:22 111 183.8 TRQX 606184410199623000
20/03/2024 08:18:22 77 183.8 TRQX 606184410199623000
20/03/2024 08:18:22 93 183.8 TRQX 606184410199623000
20/03/2024 08:18:22 451 183.8 TRQX 606184410199623000
20/03/2024 08:18:22 284 183.8 TRQX 606184410199623000
20/03/2024 08:18:22 1690 183.8 TRQX 606184410199623000
20/03/2024 08:18:22 2555 183.8 CHIX 592110659738099000
20/03/2024 08:18:22 1484 183.8 CHIX 592110659738099000
20/03/2024 09:15:37 610 184 BATE 606184410200931000
20/03/2024 09:15:37 71 184 BATE 606184410200931000
20/03/2024 09:15:37 1604 184 BATE 606184410200931000
20/03/2024 09:15:45 1251 183.9 XLON 606184410200934000
20/03/2024 09:29:36 2447 183.9 XLON 592110659739785000
20/03/2024 09:29:36 1204 183.9 XLON 606184410201249000
20/03/2024 09:35:27 1556 183.9 XLON 606184410201389000
20/03/2024 09:35:27 353 183.9 XLON 606184410201389000
20/03/2024 09:45:53 1825 184 XLON 592110659740151000
20/03/2024 09:47:05 2093 183.8 BATE 592110659740177000
20/03/2024 09:47:15 1972 183.7 XLON 592110659740180000
20/03/2024 09:57:08 210 183.7 BATE 606184410201883000
20/03/2024 09:57:11 1650 183.7 BATE 606184410201885000
20/03/2024 15:40:02 1485 184 XLON 592110659749815000
20/03/2024 15:40:02 1484 184 BATE 592110659749815000
20/03/2024 15:40:02 1765 184 AQXE 606184410210965000
20/03/2024 15:40:02 1870 184 BATE 606184410210965000
20/03/2024 15:40:08 1589 184 BATE 592110659749818000
20/03/2024 15:40:08 2600 184 XLON 606184410210968000
20/03/2024 15:40:08 368 184 XLON 606184410210968000
20/03/2024 15:43:58 157 184 CHIX 592110659749955000
20/03/2024 15:43:58 1327 184 CHIX 592110659749955000
20/03/2024 15:43:58 384 184 XLON 592110659749955000
20/03/2024 15:43:58 299 184 XLON 592110659749955000
20/03/2024 15:43:58 1072 184 XLON 592110659749955000
20/03/2024 15:43:58 946 184 BATE 606184410211101000
20/03/2024 15:43:58 2065 184 XLON 606184410211101000
20/03/2024 15:43:58 538 184 BATE 606184410211101000
20/03/2024 16:00:21 1484 184 BATE 592110659750548000
20/03/2024 16:00:21 2428 184 BATE 592110659750548000
20/03/2024 16:00:21 1484 184 CHIX 606184410211679000
20/03/2024 16:00:21 2030 184 BATE 606184410211679000

Ends

For further information please contact:

Paul Checketts, Head of Investor Relations, tel: +44 (0) 7718 195 074 or email: [email protected]

Marcus De Ville, Head of Media Relations, tel: +44 (0) 7738 898 550 or email: [email protected]

About Serco

Serco brings together the right people, the right technology and the right partners to create innovative solutions that make positive impact and address some of the most urgent and complex challenges facing the modern world.  With a primary focus on serving governments globally, Serco's services are powered by more 50,000 people working across defence, space, migration, justice, healthcare, mobility and customer services. Serco's core capabilities include service design and advisory, resourcing, complex programme management, systems integration, case management, engineering, and asset & facilities management.

Underpinned by Serco's unique operating model, Serco drives innovation and supports customers from service discovery through to delivery. More information can be found at www.serco.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSJMMRTMTJTBFI

Talk to a Data Expert

Have a question? We'll get back to you promptly.